KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099,490 | -27.6% | 79,100 | +19.7% | 0.00% | 0.0% |
| Q2 2023 | $1,519,639 | -33.4% | 66,100 | -14.2% | 0.00% | -50.0% |
| Q1 2023 | $2,281,510 | +12.3% | 77,000 | -5.4% | 0.00% | +100.0% |
| Q4 2022 | $2,031,744 | +17.1% | 81,400 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $1,735,000 | +11.9% | 79,700 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $1,550,000 | -45.2% | 78,700 | +17.6% | 0.00% | -50.0% |
| Q1 2022 | $2,831,000 | -27.9% | 66,900 | +8.3% | 0.00% | 0.0% |
| Q4 2021 | $3,924,000 | +10.4% | 61,800 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $3,554,000 | +196.7% | 60,500 | +144.9% | 0.00% | +100.0% |
| Q2 2021 | $1,198,000 | +22.4% | 24,700 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $979,000 | -37.3% | 25,200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,562,000 | – | 25,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |